Suture Anchor Devices Market Set to Reach USD 1180.16 million by 2032 Driven by Minimally Invasive Surgery Trends

Global Suture Anchor Devices Market Overview

The global suture anchor devices market was valued at USD 863.40 million in 2024 and is expected to reach USD 1,180.16 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.27% between 2025 and 2032. The market is witnessing steady growth, fueled by increasing cases of sports injuries, rising orthopedic disorders, and a growing geriatric population seeking joint repair surgeries. The adoption of advanced arthroscopic surgery techniques and the introduction of bioresorbable and knotless anchors have expanded clinical indications for procedures involving the shoulder, knee, hip, and ankle. Additionally, the rising prevalence of ambulatory surgery centers (ASCs) and outpatient procedures is further propelling demand globally.

In the United States, the suture anchor devices market is projected to grow from USD 0.70 million in 2024 to USD 1.01 million by 2032, at a CAGR of 4.70% during the forecast period. The dominance of the U.S. market is attributed to the high volume of orthopedic and sports injury procedures, an established healthcare infrastructure, availability of minimally invasive surgery, and favorable reimbursement policies. Leading manufacturers, such as Smith+Nephew, Stryker, and Arthrex, have also strengthened market growth through continuous product innovation.

Explore Market Dynamics: Request Your Sample Report Now: https://www.snsinsider.com/sample-request/7876

Technological Advancements and Product Innovations Driving Growth

The demand for suture anchor devices is increasingly supported by advancements in arthroscopic and minimally invasive surgeries. These techniques allow smaller incisions, reduced tissue damage, and shorter recovery times compared to traditional open surgeries. Suture anchors play a critical role in soft tissue-to-bone repair, particularly in rotator cuff, labral tear, and meniscal fixation procedures. Hospitals and ASCs increasingly require compact, efficient, and reliable suture anchors to accommodate the rising volume of minimally invasive procedures.

Smith+Nephew’s Q-FIX Knotless All-Suture Anchor, launched in July 2025, exemplifies this innovation, offering ultra-low displacement, simplified insertion, and superior fixation strength across shoulder, hip, and ankle surgeries. Medacta’s X-Twist anchor platform, available in both knotted and knotless configurations, has also contributed to the trend toward versatile, minimally invasive systems that streamline operative procedures.

Material innovation has further enhanced market growth. Modern suture anchors use high-tech materials, including PEEK, carbon-reinforced PEEK, and biodegradable polymers such as PLLA and PLGA. These materials improve biocompatibility, reduce postoperative complications, and in the case of absorbable anchors, eliminate the need for implant removal. New designs, including knotted and tape anchor systems, provide enhanced fixation strength, shorten operative times, and simplify surgical procedures, driving adoption among surgeons seeking better patient outcomes. A recent MDPI systematic review confirms that bioabsorbable PLLA/PLGA anchors achieve pull-out strength comparable to non-absorbable anchors, degrading within 7–90 months, supporting resorbable device use.

Stryker’s Citrefix system represents a hybrid approach, combining a citrate-based bioresorbable body with a PEEK eyelet for tissue-friendly healing and structural integrity, reflecting the ongoing innovation in suture anchor design.

Challenges Restraining Market Expansion

Despite its growth trajectory, the suture anchor devices market faces certain restraints, primarily the high cost of advanced devices. Novel implants, including knotless, tape-based, or bioabsorbable anchors, often carry higher price tags compared to traditional metallic or knotted implants. In cost-sensitive regions and developing countries, limited healthcare budgets and restricted public funding further hinder adoption. Additional adaptation costs, including specialized surgical instruments, arthroscopic tools, and postoperative care, may also discourage providers and patients from transitioning to advanced systems despite their clinical advantages.

Segmentation Insights

By Product Type, non-absorbable suture anchors dominated in 2024, holding a 54.28% market share due to their strength and long-term fixation capabilities, particularly in high-load procedures like rotator cuff and knee ligament repairs. Absorbable anchors, however, are projected to register the highest CAGR during the forecast period due to growing demand for resorbable, biocompatible materials that reduce long-term tissue irritation and eliminate the need for removal surgeries.

In terms of Material, PEEK and carbon-reinforced PEEK anchors led the market in 2024 with a 33.26% share, thanks to their mechanical strength, biocompatibility, and MRI/CT compatibility. Bio-absorbable polymers (PLLA and PLGA) are expected to grow fastest, particularly in younger and more active patient populations where permanent implants are less desirable.

By Tying Type, knotless anchors held a 47.16% market share in 2024 due to their simplified procedures and consistent fixation, while tape-based anchors are expected to be the fastest-growing segment. Tape anchors distribute load more evenly across tissues, reduce cut-through risk, and are increasingly preferred for delicate or degenerative tissues in shoulder and knee repairs.

By Application, the shoulder rotator cuff segment dominated in 2024 with a 35.5% share, driven by the high prevalence of rotator cuff injuries in elderly and athletic populations. Hip labral and FAIS procedures are projected to grow fastest, supported by advancements in hip arthroscopy and early diagnosis in active populations.

By End-Use, hospitals dominate with a 68.2% market share, performing complex orthopedic surgeries with advanced surgical facilities and reimbursement support. Ambulatory surgical centers (ASCs) are expected to grow at the fastest CAGR, driven by the shift toward cost-effective, minimally invasive procedures with quicker recovery times.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis: https://www.snsinsider.com/reports/suture-anchor-devices-market-7876

Regional Market Analysis

North America led the global suture anchor devices market in 2024 with a 42.10% share, benefiting from a well-established healthcare infrastructure, early adoption of technology, and a high volume of orthopedic procedures. Asia Pacific is emerging as the fastest-growing region due to aging populations, rising sports injuries, and increasing access to orthopedic care in countries like China, India, and Japan. Europe continues to expand steadily, with Germany, the U.K., France, and Italy leading adoption through awareness of minimally invasive procedures and availability of trained surgeons. Latin America and the Middle East & Africa exhibit moderate growth, fueled by private healthcare expansion and government investment, though reimbursement and skill shortages pose challenges.

Competitive Landscape and Recent Developments

Key players in the global suture anchor devices market include Smith & Nephew, Zimmer Biomet, Arthrex, Johnson & Johnson (DePuy Synthes), Stryker, CONMED, Medtronic, Parcus Medical, Wright Medical (Enovis), Teknimed, Enovis (DJO), Integra LifeSciences, Double Medical, Anika Therapeutics, Medartis, OrthoMed, B. Braun Melsungen, OrthAlign, Ceterix Orthopaedics, and Teleflex Medical.

Recent innovations include Smith+Nephew’s Q-FIX Knotless All-Suture Anchor launched in July 2025, and Stryker’s Citrefix system launched in January 2023. Both devices reflect ongoing efforts to improve surgical versatility, fixation strength, and patient outcomes.

Future Outlook

The suture anchor devices market is expected to maintain a steady growth trajectory through 2032. Innovations in bioresorbable materials, minimally invasive surgery techniques, and tape-based anchor systems will continue to enhance adoption, especially in outpatient and ambulatory care settings. Rising sports injury prevalence, the aging global population, and growing orthopedic surgery awareness will drive further demand, particularly in North America and Asia Pacific.

Conclusion

The global suture anchor devices market is witnessing significant growth, fueled by technological advancements, minimally invasive surgical trends, and increasing orthopedic procedures worldwide. With continuous innovation in design and materials, expanding clinical applications, and growing awareness among healthcare providers, the market is poised to reach USD 1.18 billion by 2032. Despite challenges like high device costs and limited reimbursement in developing regions, the overall outlook remains robust.

Other Trending Reports

Midline Catheter Market

Laboratory Supplies Market

Real World Evidence Solutions Market

Multiple Myeloma Market